Kala Bio earnings were -$10.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest KALA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.6M, down 2.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KALA reported annual earnings of -$27.0M, with -29.9% growth.
On KALA's earnings call on Aug 21, 2026, Kala Bio (NASDAQ: KALA) reported Q2 2026 earnings per share (EPS) of -$21.32, up 75.11% year over year. Total KALA earnings for the quarter were -$1.58 million. In the same quarter last year, Kala Bio's earnings per share (EPS) was -$85.64.
As of the last Kala Bio earnings report, Kala Bio is currently losing money. Kala Bio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$10.08 million, a 72.92% decrease year over year.
What was KALA's earnings growth in the past year?
As of Kala Bio's earnings date in Aug 21, 2026, Kala Bio's earnings has grown year over year. KALA earnings in the past year totalled -$10.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.